1.  Popovych O, Gibofsky A, Berne DH: Medium effects for single ions in acetonitrile and ethanol-water solvents based on reference electrolyte assumptions. Analytical Chem 44: 811-817, 1972.

 2.  Gibofsky A, Terasaki PI: Trypsinization of lymphocyte for HL-A typing. Transplantation 13: 192-195, 1972.

 3.  Gibofsky A, Jaffe EA, Fotino M, Becker CG:  The identification of HL- A antigens on fresh and cultured human endothelial cells. J Immunol 115: 730-733, 1975.

 4.  Gibofsky A, Winchester RJ, Hansen J, Patarroyo M, Dupont B, Paget SA, Lahita RG, Halper J, Fotino M, Yunis E, Kunkel HG: Contrasting patterns of newer histocompatibility determinants in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 21: 134-139, 1978.

 5.  Gibofsky A, Winchester RJ, Patarroyo M, Fotino M, Kunkel HG:  Disease associations of the Ia-like human alloantigens: contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med 148: 1728-1732, 1979.

 6.  Winchester RJ, Gibofsky A, Patarroyo M, Wang CI, Kunkel HG:  The human Ia system: Differentiation allo-antigens relevant to disease. Streptococcal Disease and the Immune Response, edited by J Zabriskie, SE Read, Academic Press, 1978.

 7.  Patarroyo ME, Winchester RJ, Vejarano A, Gibofsky A,  Zabriskie JB, Chalem F, Orozco O, Blanco E, Kunkel HG: Association of a particular B cell alloantigen with susceptibility to rheumatic fever. Streptococcal Disease and the Immune Response, edited by J Zabriskie, SE Read, Academic Press, 1978.

 8.  Winchester RJ, Wang CY, Gibofsky A, Kunkel HG, Lloyd KO,  Old LJ: Expression of Ia-like antigens on  cultured human malignant melanoma cell lines. Proc Natl Acad Sci USA  75: 6235-6239, 1978.

 9.  Suthanthiran M, Fotino M, Gibofsky A, Cheign JS,  Stenzel KH, Rubin AL, Novogrodsky A: Adverse presensitization: detection by utilization of B lymphoblastoid cell panel. Transplant Proc 11(2): 1263-1264, 1979.

10.  Winchester RJ, Patarroyo M, Gibofsky A, Kunkel HG: B-cell alloantisera as probes for the immunogenetics of three rheumatic diseases. Genetics and the Immune Response, edited by N Rose, Elsevier North Holland, 1978, pp. 113-124.

11.  Patarroyo ME, Winchester RJ, Vejarano A, Gibofsky A, Zabriskie JB, Chalem F, Orozco O, Blanco E, Kunkel HG: Association of a particular B cell alloantigen with susceptibility to rheumatic fever. Nature 278: 173-174, 1979.

12.  Karpatkin SA, Fotino M, Gibofsky A, Winchester RJ: Association of HLA-DRw2 with autoimmune thrombocytopenic purpura.   J Clin Invest 63: 1085-1088, 1979.

13.  Steere AC, Gibofsky A, Hardin JA, Winchester RJ, Malawista SE: Lyme arthritis: Clinical and immunogenetic differentiation from rheumatoid arthritis. Ann Intern Med 90: 896-901, 1979.

14.  Paget SA, Gibofsky A:  Immunopathogenesis of rheumatoid arthritis.   Am J Med  67: 961-970, 1979.

15.  Yu DTY, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG: Peripheral blood
Ia positive T cells: Increases in certain diseases and following immunization.  J Exp Med  151: 90-101,1980.                     

16.  Gibofsky A (Associate Editor): Manual of Rheumatology and Outpatient Orthopedic  Disorders, edited by Beary J, Christian CL, Sculco T. Boston: Little, Brown and Co., 1981.

17.  Gibofsky A: Immunogenetics of the rheumatic diseases.Manual of Rheumatology and Outpatient Orthopedic Disorders, edited by Beary J, Christian CL, Sculco T.  Boston: Little, Brown and Co., 1981, Revised 1987.  Revised 1998.

18.  Gibofsky A:  Reiters syndrome.  Manual of Rheumatology and Outpatient Orthopedic Disorders, edited by Beary J, Christian CL, Sculco T. Boston: Little, Brown and Co., 1981, Revised 1987.  Revised 1998.

19.  Gibofsky A: Enteropathic arthritis. Manual of Rheumatology and Outpatient Orthopedic Disorders, edited by Beary J, Christian CL, Sculco T.  Boston: Little, Brown and Co. 1981, Revised 1987.  Revised 1993.

20.  Sheldon WB, Lurie DP, Maricq HR, Kahaleh MB, Delustro FA, Gibofsky A, LeRoy EC: Three siblings with scleroderma and two with Raynaud's phenomenon from a single kindred.  Arthritis Rheum 24: 668-676, 1981. 

21.  Libby DM, Gibofsky A, Fotino M, Briscoe W, Waters SJ, Smith JP:  Immunogenetic and clinical findings in idiopathic pulmonary fibrosis:  Association with HLA-DR2. Am Rev Resp Dis, 1982.

22.  Gibofsky A: Pac-Man phalanx.  Arthritis Rheum  26: 214, 1983.

23.  Lahita RG, Chiorazzi N, Gibofsky A, Winchester RJ, Kunkel HG:  Familial lupus in males.  Arthritis Rheum  26: 39-44, 1983.

24.  Parris TM, Kimberly RP, Inman RD, McDougal JS, Gibofsky A, Christian CL: Defective Fc receptor mediated function of the mononuclear phagocyte system in lupus nephritis.  Ann Intern Med  97:  526, 1982.

25.  Ambinder J, Chiorazzi N, Gibofsky A, Fotino M, Kunkel HG:  Reduced suppressor cell function in normal individuals of the HLA-DR3 phenotype.  Clin Immunol  Immunopathol  23: 269-274, 1982.

26.  Lockshin MD, Gibofsky A, Peebles CL, Gigli I, Fotino M, Hurwitz S: Neonatal lupus erythematosus with heart block: Family study of a patient with anti-SS-A and SS-B antibodies.  Arthritis Rheum 26: 210- 213, 1983.

27.  Kimberly RP, Gibofsky A, Salmon JE, Fotino M:  Impaired Fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MTl-positive healthy young adults. J Exp Med  157: 1698-1703, 1983.

28.  Salmon JE, Kimberly RP, Gibofsky A, Fotino M:  Defective mononuclear  phagocyte function in systemic lupus erythematosus:  Dissociation of Fc receptor-ligand binding and internalization.  J Immunol 133: 2525- 2531, 1984.

29.  Salmon JE, Kimberly RP, Gibofsky A, Fotino M:  Altered phagocytosis by monocytes from HLA-DR2 and DR3 positive healthy adults is Fe receptor-mediated.  J Immunol 136: 3625-3631, 1986.

30.  Zabriskie JB, Gibofsky A:  Genetic control of the susceptibility to infection with pathogenic bacteria. In: Current Topics in Microbiology and Immunology, pp. 1-20, edited by D.E. Briles, Springer Verlag, 1986.

31.  Gibofsky A, Kalb P:  Acquired immunodeficiency syndrome: An overview of medical and legal aspects. NYS Bar Association Labor and Employment Newsletter 11: 25-29, 1986.

32.  Zabriskie JB, Gibofsky A, Khanna A, Kemeny E:  Rheumatic Fever: A model for the pathologic consequences of microbial host mimicry.  In:  International Textbook of Cardiology, edited by T.O. Cheng, Pergamon Press, 1986.

33.  Gibofsky A:  Genetics of Hajdu-Cheney Syndrome.  Arthritis Rheum 30: 718, 1987.

34.  Gibofsky A, Williams RC, Jr, Zabriskie JB:  Immunological aspects of acute rheumatic fever. Clin Allergy Immunol 1: 577-590, 1987.

35.  Gibofsky A, Schwartzman S:  Rheumatology. In: Soft Tissue Injury, pp. 1023-1070, edited by C.H. Wecht, Kluwor Publishing, 1987.

36.  Gibofsky A, Williams RC, Jr, Zabriskie JB:  Clinical and immunological aspects of rheumatic fever. In: Infections in Rheumatic Diseases, pp. 367-373, edited by L.R. Espinoza et. al., Grune and Stratton, 1988.

37.  Lafferty RM, Gibofsky A: Regulatory and legal issues in the reprocessing and reuse of hemodialyzers: A critical overview. J Legal Med 9: 279-311, 1987.

38.  Gibofsky A, Laurence J: AIDS: Current medical and scientific aspects. J Legal Med 9: 497-508, 1988.

39.  Gibofsky A, Schwartzman S:  Rheumatology. In: Medicolegal Primer, edited by CH Wecht. ACLM Foundation Press, 1989.

40.  Gibofsky A, Kalb P:  AIDS: A current overview of medical and legal aspects. In: Hospital Liability: Law and Practice. Edited by MM Bertolet and LS Goldsmith, PLI Press, 1988.

41.  Gibofsky A, Froude JRL, Zabriskie JB: Immunology of rheumatic fever in adults. Current Opinion in Rheumatology 1: 205-209, 1989.

42.  Khanna A, Gibofsky A, Buskirk DR, Williams RC, Crow MK, Menon A, Fotino M, Reid HM, Poon-King T, Rubenstein P, Zabriskie JB: Presence of non-HLA B cell antigens in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest 83: 1710- 1716, 1989.    

43.  Froude JRL, Gibofsky AG, Buskirk DR, Khanna A, Zabriskie JB: Cross- reactivity between streptococcus and human tissue: a model of molecular mimicry and autoimmunity.  Current Topics in Microbiology and Immunology 145: 4-26, 1989.

44.  Kimberly RP, Salmon JE, Edberg JC, Gibofsky A: The role of Fc-gamma receptors in mononuclear phagocyte system function. Clin Exp Rheum 7: 103-108, 1989.

45.  Gibofsky A, Khanna A, Suh E, Zabriskie JB: The genetics of rheumatic fever:
 
Relationship to streptococcal infection and autoimmune disease. J Rheum 18: 1-18,   1991.

46.  Revenson TA, Schiaffino KM, Majerowitz D, Gibofsky A: Social support as a double-edged sword: The relation of positive and problematic support to depression among rheumatoid arthritis patients.  Soc Sci Med 33: 807-813, 1991.

47.  Mahoney R, Gibofsky A: The Americans with Disabilities Act of 1990: Changes in existing protection and the effect on the private health services provider.  J Legal Med 13: 51-75, 1992.

48.  Porges DY, Porges A, Gibofsky A:  Etiology and genetics of collagen diseases.  Clin Derm 10: 473-481, 1992.

49.  Gibofsky A, Kaple MH:  The role of professional education in improving quality of life.  Arthritis Health Care and Research 5: 193-195, 1992.

50.  Gibofsky A, Zabriskie JB:  Rheumatic fever. In: Oxford Textbook of Rheumatology, edited by P.J. Maddison et al., Oxford University Press, p. 613-619, Oxford, 1993.

51.  Gibofsky A, Zabriskie JB: Rheumatic fever. In: Manual of Rheumatology and Outpatient Orthopedic Disorders, 3rd edition.  Edited by S.A. Paget et al., Little Brown & Co., 1993.

52.  Gibofsky A, Zabriskie JB:  New concepts in post-streptococcal infection.  Bull Rheum Dis 42: 5-8, 1993.

53.  Mahoney R, Gibofsky A:  An update on the Americans with Disabilities Act. In:  Legal Medicine, edited by C.H. Wecht, Butterworth Publishers, pp. 213-239, 1993.

54.  Spiera RF, Gibofsky A, Spiera H:  Silicone gel-filled breast implants and connective tissue disease: An overview.  J Rheum 21: 239-246, 1994.

55.  Mudge OS, Gibofsky A:  The developing application of antitrust laws to hospital mergers.  J Legal Med  15: 355-384, 1994.

56.  Spiera RF, Gibofsky A, Spiera H:  Immunological reactions to silicone implants:  Risk and management.  Clin Immunotherap 1(6): 406-412, 1994.

57.  Revensen TA, Gibofsky A:  Social support and coping mechanisms in the rheumatic diseases.  Bull Rheum Dis 44: 5-8, 1995.

58.  Miskovitz P, Gibofsky A:  Risk management in endoscopic practice.  Gastroent Clin N.A. 5: 391-403, 1995.

59.  Gibofsky A, Hirsh HL:  Evaluation of impairment and disability.  In:  Legal Aspects of Medical Dynamics, 3rd ed.  S.S. Sanbar (ed), Mosby, pp. 531-533, 1995.

60.  Spiera H, Spiera R, Gibofsky A:  Silicone breast implants and connective tissue disease.  J Rheum 21: 1979-1980, 1995.

61.  DiGiovanni L, Gibofsky A:  Medicare fraud regulations and the implications for joint ventures:  Are we working at cross purposes?  In:  Legal Medicine, 1995.  Edited by C.H. Wecht, Butterworth Publishers, pp. 279-303, 1995.

62.  Gibofsky A, Zabriskie JB:  Treatment of rheumatic fever.  In: Conn's Current Therapy, 1996.  Edited by R.E. Raker, Saunders Publishing, p. 133-136, 1996.

63.  Gibofsky A, Zabriskie JB:  Rheumatic fever.  In:  Textbook of Arthritis, 12th edition.  Edited by W.A. Koopman. 

64.  Gibofsky A:  Legal issues in allergy and clinical immunology.  J Allergy Clin Immunol 98: 334-338, 1996.

65.  Gibofsky A:  Liability issues in the treatment of patients with rheumatic diseases.  Am J Med 102: 40S-42S, 1997.

66.  Georgescu L, Riker C, Gibofsky A, Barland P:  The co-occurrence of acute rheumatic fever and AIDS.  J Rheum 24: 404-406, 1997.

67.  Snyder J, Gibofsky A:  Contrasting theories of causation in the rheumatic diseases. In:  Environmental Agents and the Rheumatic Diseases,p217-232. edited by J. Varga.  Oxford Press. 1999.

68.  Gibofsky A, Zabriskie JB:  Rheumatic fever.  In:  Primer of The Rheumatic Diseases, 11th edition, pp 212-215.  Edited by J Klippel, Arthritis Foundation, 1997.

69.  Benjamin D, Gibofsky A:  Legal aspects of treating patients with corticosteroids.  In: The Clinical Use of Corticosteroids.  Edited by A Lin and SA Paget.  In press, 2001.

70.  Gibofsky A, Hirsh HL:  The impaired and/or disabled patient.  In:  Legal Aspects of Medical Dynamics, 4th edition.  Edited by SS Sanbar, Mosby Publishing.  In press, 1997.

71.  Gibofsky A, Kerwar SS, Zabriskie JB: Rheumatic fever: The relationships between host microbe and genetics. Rheum Dis Clin NA 24: 237-260, 1998.

72.  Zabriskie JB, Kerwar SS, Gibofsky A: The arthritogenic properties of microbial antigens.  Rheum Dis Clin NA 24: 211-226, 1998.

73.  Kyriakos K, Gibofsky A: Enteropathic arthritis. In: Manual of Rheumatology and Outpatient Orthopedic Disorders, 4th Edition.  Edited by  Paget SA , Gibofsky A, and Beary J. Lippincott Williams & Wilkins.  2000.

74.      Atiquzzaman BM, Ricciardi DD, Yazici Y, Gibofsky A: Lupus erythematosus cells in the kidney and synovial fluid. Arthritis Rheum 169:44, 2001.

75.    Gibofsky A, Zabriskie JB: Rheumatic fever. In: Manual of Rheumatology and Outpatient Orthopedic Disorders, 4th edition.  Edited by  Paget SA , Gibofsky A, and Beary J. Lippincott Williams & Wilkins.  2000

76.    Yazici Y, Gibofsky A. A diagnostic approach to musculoskeletal pain. Clinical Cornerstone 2: 1-10, 1999.

77.       Lipsky  PE, Abramson SB, Breedveld  FC, Brook P, Burmeister GR, Buttgeriet F, Cannon GW, Catella-Lawson F, Crofford LJ, Doherty M, Dougados M, DuBois RN, Froelich J, Garcia-Rodriguez LA, Gibofsky A, Hernandez-Diaz S, Hochberg MC, Krause A, Liang MH, Machold K, Peloso PM, Riasz LG, Schayes B, Scheiman JM, Simon LS, Smolen J, Stichtenoth DOA, Stoekle JD, van de Putte LBA, Whelton A: Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice. J Rheumatology 27: 1338-1340, 2000.

78.      Gibofsky A: Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
           J Hypertens 20 : s25-s30, 2002.

79.  Pincus T, Gibofsky A, Weinblatt M: Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 46:851-854, 2002

80.   Yazici Y, Gibofsky A: Rheumatic fever, Sjogrens syndrome and relapsing                                 polychondritis. In: Clinical Primer of Rheumatology . Edited by Koopman WJ,  
            Boulware D and Heudebert, GR. Lippincott Williams & Wilkins.2003

81.      Gibofsky A, Williams GW, McKenna F, Fort JG: Comparing the efficacy of        
           cyclooxygenase 2-specific inhibitors in treating osteoarthritis: Appropriate trial
           design considerations and results of a randomized, placebo-controlled trial
           Arth Rheum 48: 3102-3111. 2003.

82. Pincus T, Koch G, Lei H, Mangal B, Sokka T, Moskowitz R, Wolfe F, Gibofsky A,          
      Simon L, Fort J: Patient preference for Placebo, Acetaminophen or Celecoxib Efficacy 
      Studies (PACES): Two randomized placebeo-controlled cross-over clinical trials in
      Patients with osteoarthritis of the knee or hip. Ann Rheum Dis: in press 2004.

83. Gibofsky A: Alternative Dispute Resolution. In: Legal Medicine 5th Edition. Edited by
      SS Sanbar. Elsevier 2004.

84. Bope ET, Douglass AB, Gibofsky A, Jones T, Nasir L, Palmer T, Panchil  S, Rainone F,
      Rives P, Todd K, Toombs JD : Pain Management by the Family Physician: The family
      Practice Pain Education Project. J Am Bd Fam Prac 17: S1-S12. 2004.

85. Markenson J, Palmer WR, Gibofsky A, Garjian PA, Howland J, Xia HA, Louie JS:
      Real-world safety of biologics and traditional DMARDs: observations from the RADIUS       registry. Manuscipt submitted  J Rheum 2005.

86. Gibofsky A: Combination therapy for Rheumatoid Arthritis in the age of Biologicals.
       J Hosp Spec Surg  2: 30-41,2006.

87. Weaver AL, Lautzenheiser RL, Schiff MH, Gibofsky A, Perruquet JL, Luetkemeyer J,
      Paulus H, Xia HA, Leff J: Real-world effectiveness of biologics and DMARDs in the             treatment of rheumatoid arthritis: results from the RADIUS observational registry.
      Curr Med Research Opinion 22:185-198.2006

88. Gibofsky A, Zabriskie JB: Rheumatic fever. In: Manual of Rheumatology and Outpatient       Orthopedic Disorders, 5th edition.  Edited by  Paget SA , Gibofsky A, and Beary J.              Lippincott Williams & Wilkins. 2005

89. Kyriakos K, Gibofsky A: Enteropathic arthritis. In: Manual of Rheumatology and                    Outpatient Orthopedic Disorders, 5th Edition.  Edited by  Paget SA , Gibofsky A, and          Beary J. Lippincott Williams & Wilkins. 2005.

90. Gibofsky A, Palmer WR, Goldman JA, Lautzenheiser RL, Markenson J, Weaver AL,
      Schiff MH, Keystone EC, Paulus HE, Harrison MJ, Whitmore JB, Leff JA:
      Rheumatoid arthritis disease-modifying anti-rheumatic drug intervention and utilization
      Study (RADIUS): real-world data in the management of rheumatoid arthritis.
 Curr Med Research Opinion 22: 169-184, 2006


91. Gibofsky A: An Analysis of Recent Antitrust Issues Affecting Specialty Practice: Is 
      Dermatology Immune? Seminars Cut Med & Surg 24: 137-143. 2005.

92. Niewold T, Gibofsky A: Concomitant interferon-alpha therapy and tumor necrosis factor       alpha inhibition for rheumatoid arthritis and hepatitis c. Arth Rheum 54: 2335-2337.
      2006.

93. Pincus T, Gibofsky A, Harrington JT: Improving Survival in Inflammatory Rheumatic  
      Diseases: A Neglected Goal? Curr Rheum Reports 8:401-403. 2006.

94. Gibofsky A: NSAIDs and Gastrointestinal Effects. Postgrad Med Supp May: 16-22. 
      2006   

95. Gibofsky A, Rodrigues J, Fiechtner J, Berger M, Pan S: Efficacy and safety of        valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis. Clin Therapeutics 29: 1071-1085. 2007

96. Gibofsky A, Barkin RL:  Chronic Pain in Osteoarthritis: Considerations for choosing an   extended-release opioid analgesic  . Am J Therapeutics 15: 241-255.  2008.

97. Scanzello CR, Moskowitz N, Gibofsky A: The Post-NSAID Era:  What to use now     for the pharmacologic treatment of pain and inflammation in osteoarthritis.  . Curr Pain & Headache Rep 11: 415-422. 2007

98. Kremer J, Gibofsky A, Greenberg J: The role of drug and disease registries in rheumatic disease epidemiology. Curr Opinion Rheumat 20: 123-130. 2008.

98. Gibofsky A, Harrington JT: Pay for performance: Will we get the carrot or the stick?
      Arth Care & Res  9: 1203-1206. 2008.

 100. Scanzello CR, Moskowitz N, Gibofsky A: The Post-NSAID Era:  What to use now     for the pharmacologic treatment of pain and inflammation in osteoarthritis.  Curr      Rheum Rep 10: 49-56.2008

101. Furst DE, Keystone EC, Kirkham B, Fleischmann R, Meese P, Breedveld FC,
        Smolen JS, Kalden JR, Burmester GR, Braun J, Emery P, Winthrop K, Bresnihan B
        De Benedetti F, Dorner T, Gibofsky A, Schiff MH, Sieper J, Singer N,
        Van Riel PLCM, Weinblatt ME, Weisman MH: Updated consensus statement on
        Biological agents for the treatement of rheumatic diseases 2008.
        Ann Rheum Dis 67s3:2-25. 2008

102. Zabriskie JB, Gibofsky A, Van Voorhis W, Buckner FS, Rose NR: Immunological  
        aspects of cardiac disease. In:  Essential Clinical Immunology . Edited by    
        JB Zabriskie. Cambridge University Press. 2009.

103. Singer O, Gibofsky A: Review of Disease Modifying Antirheumatic Drug Use in          Rheumatoid Arthritis. Intl J Adv Rheum 6:120-129. 2009.